MMSIMerit Medical Systems, Inc.
$87.22+4.4% 1Y
$87.22
$60.3152 weeks$93.18
The financials
Merit Medical Systems, Inc. by the numbers
Merit Medical Systems, Inc. (MMSI) reported revenue of $419M in Q2 2026 (quarter ended Jun 30, 2026), up 9.5% from the same quarter a year earlier. That came with a gross margin of 51% and net income of $39M (9.3% of revenue). For the full year FY2025, revenue was $1.52B (+12% year on year) and net income $128M. Its largest product in Q2 2026 was Therapeutic at $138M, 35% of the disclosed total, well ahead of Foundational Original Equipment Manufacturer at 12%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $419M | $382M | +9.5% |
| Gross profit | $215M | $184M | +17% |
| Operating income | $60M | $47M | +29% |
| Net income | $39M | $33M | +19% |
| Diluted EPS | $0.65 | $0.54 | +20% |
| Product | Revenue | Share |
|---|---|---|
| Therapeutic | $138M | 35% |
| Foundational Original Equipment Manufacturer | $48M | 12% |
| Foundational Vascular Intervention | $42M | 11% |
| Therapeutic Vascular Intervention | $34M | 8.7% |
| Therapeutic Cardiac Therapies | $29M | 7.2% |
| Foundational Procedural Solutions | $28M | 7.1% |
| Therapeutic Oncology | $26M | 6.5% |
| Therapeutic Endoscopy | $24M | 6.0% |
| Therapeutic Original Equipment Manufacturer | $13M | 3.2% |
| Therapeutic Renal Therapies | $13M | 3.2% |
| Product And Service Other | $1.2M | 0.3% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $394.9M (+212%)
Product And Service Other grew +257% year on yearFoundational Procedural Solutions -12% year on year
Segment Latestquarter on quarteryear on year
- Therapeutic$137.9M$137.9Mquarter on quarter +9.1%year on year +15%+9.1%+15%
- Foundational Original Equipment Manufacturer$48.3M$48.3Mquarter on quarter n/ayear on year +12%n/a+12%
- Foundational Vascular Intervention$41.7M$41.7Mquarter on quarter n/ayear on year +19%n/a+19%
- Therapeutic Vascular Intervention$34.4M$34.4Mquarter on quarter n/ayear on year +6.8%n/a+6.8%
- Therapeutic Cardiac Therapies$28.5M$28.5Mquarter on quarter n/ayear on year +24%n/a+24%
- Foundational Procedural Solutions$27.9M$27.9Mquarter on quarter n/ayear on year -12%n/a-12%
- Therapeutic Oncology$25.8M$25.8Mquarter on quarter n/ayear on year +7.6%n/a+7.6%
- Therapeutic Endoscopy$23.6M$23.6Mquarter on quarter n/ayear on year +29%n/a+29%
- Therapeutic Original Equipment Manufacturer$12.8M$12.8Mquarter on quarter n/ayear on year +31%n/a+31%
- Therapeutic Renal Therapies$12.7M$12.7Mquarter on quarter n/ayear on year -0.81%n/a-0.81%
- Product And Service Other$1.2M$1.2Mquarter on quarter n/ayear on year +257%n/a+257%
Medical Instruments & Supplies
Ranks #5 of 21 by RyuScore